bioRxivBioengineering
Creation of X-linked Alport Syndrome Rat Model with Col4a5 Deficiency
M. Namba, T. Kobayashi, M. Kohno, T. Koyano, T. Hirose, M. Fukushima, M. Matsuyama
Abstract
Alport syndrome is an inherited chronic human kidney disease, characterized by glomerular basement membrane abnormalities. This disease is caused by mutations in COL4A3, COL4A4, or COL4A5 gene. The knockout mice for Col43, Col44, and Col45 are developed and well characterized for the study of Alport syndrome. However, disease progression and effects of pharmacological therapy depend on the genetic variability. This model is reliable only to mice. Therefore in this study, we created a novel Alport syndrome rat model utilizing rGONAD technology. Col45 deficient rats showed hematuria, proteinuria, high levels of BUN, Cre, and then died at 18 to 28 weeks of age (Hemizygous mutant males). Histological and ultrastructural analyses displayed the abnormalities including parietal cell hyperplasia, mesangial sclerosis, and interstitial fibrosis. Then, we demonstrated that 3/4/5 (IV) and 5/5/6 (IV) chains of type IV collagen disrupted in the Col45 deficient rats. Moreover, immunofluorescence analyses revealed that some glomeruli of Col45 mutant rats were found to be disrupted from postnatal day 0. Thus, Col45 mutant rat is a reliable candidate for Alport syndrome model for underlying the mechanism of renal diseases and further identifying potential therapeutic targets for human renal diseases.
- organism: rat
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: protein folding & dynamics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Drosophila model to screen Alport syndrome COL4A5 variants for their functional pathogenicity
Jianli Duan, Pei Wen, … Zhe Han·bioRxiv·Mar 6, 2024
- Glomerular Elastic Modulus and Gene Expression PatternsDefine Two Phases of Alport Nephropathy
Joon‐Ho Yoon, Zhenan Liu, … Richard Tyler Miller·bioRxiv·Feb 26, 2024
- mRNA Therapy for Alport Syndrome
Brian J. Parrett, Michael A. Barry·bioRxiv·Jan 21, 2026
- Therapeutic splice modulation of COL4A5 reinstates collagen IV assembly in an organoid model of X-linked Alport syndrome
Hassan Saei, Bruno Estebe, … Guillaume Dorval·JCI InsightPeer-reviewed·Dec 18, 2025
- Novel Variants in COL4A3 and COL4A4 are Causes of Alport Syndrome in Rio Grande do Norte, Brazil
Washington Candeia de Araújo, Raul Maia Falcão, … Selma M. B. Jerônimo·bioRxiv·Dec 17, 2019
- An Alport variant illuminates the bioactivity of the collagen IV α565- α121 scaffold in Bowman's capsule.
Elena N. Pokidysheva, Rajan Koirala, … Billy G. Hudson·bioRxiv·Feb 25, 2026